Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Hot Pursuit
Close

Scrips, which has significant changes during the market hours.

 
Mankind Pharma Ltd gains for third straight session
21-Apr-26 13:05Hrs IST

Mankind Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 2188.2, up 2.06% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.72% on the day, quoting at 24539.15. The Sensex is at 79191.47, up 0.85%. Mankind Pharma Ltd has gained around 13.53% in last one month.

Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 1.89% in last one month and is currently quoting at 22456.75, up 0.06% on the day. The volume in the stock stood at 1.76 lakh shares today, compared to the daily average of 5.54 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 2178.8, up 1.87% on the day. Mankind Pharma Ltd is down 15.17% in last one year as compared to a 1.54% jump in NIFTY and a 4.82% jump in the Nifty Pharma index.

The PE of the stock is 50.08 based on TTM earnings ending December 25.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise